vs
Adaptive Biotechnologies Corp(ADPT)与AST SpaceMobile, Inc.(ASTS)财务数据对比。点击上方公司名可切换其他公司
Adaptive Biotechnologies Corp的季度营收约是AST SpaceMobile, Inc.的1.3倍($70.9M vs $54.3M),过去两年AST SpaceMobile, Inc.的营收复合增速更高(173.4% vs 28.1%)
ExpreS2ion Biotechnologies是一家丹麦生物技术企业,总部位于丹麦霍尔斯霍姆,专注于新型疫苗和免疫疗法产品的研发,在纳斯达克第一北增长市场瑞典板块挂牌上市。
AST SpaceMobile是总部位于美国得克萨斯州米德兰的上市卫星设计与制造企业,目前正搭建SpaceMobile卫星星座,打造可直接对接未改装普通智能手机的天基蜂窝宽带网络,面向全球偏远及通信服务薄弱地区提供4G、5G宽带覆盖服务。
ADPT vs ASTS — 直观对比
营收规模更大
ADPT
是对方的1.3倍
$54.3M
两年增速更快
ASTS
近两年复合增速
28.1%
损益表 — Q1 FY2026 vs Q1 FY2026
| 指标 | ||
|---|---|---|
| 营收 | $70.9M | $54.3M |
| 净利润 | $3.4M | — |
| 毛利率 | 73.6% | — |
| 营业利润率 | -27.1% | -560.4% |
| 净利率 | 4.7% | — |
| 营收同比 | 35.1% | — |
| 净利润同比 | — | — |
| 每股收益(稀释后) | — | — |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比,按日历期对齐,财年错位的公司也能正确匹配
营收
ADPT
ASTS
| Q1 26 | $70.9M | $54.3M | ||
| Q4 25 | $71.7M | $54.3M | ||
| Q3 25 | $94.0M | $14.7M | ||
| Q2 25 | $58.9M | — | ||
| Q1 25 | $52.4M | — | ||
| Q4 24 | $47.5M | — | ||
| Q3 24 | $46.4M | — | ||
| Q2 24 | $43.2M | — |
净利润
ADPT
ASTS
| Q1 26 | $3.4M | — | ||
| Q4 25 | $-13.6M | $-74.0M | ||
| Q3 25 | $9.5M | $-122.9M | ||
| Q2 25 | $-25.6M | — | ||
| Q1 25 | $-29.9M | — | ||
| Q4 24 | $-33.7M | — | ||
| Q3 24 | $-32.1M | — | ||
| Q2 24 | $-46.2M | — |
毛利率
ADPT
ASTS
| Q1 26 | 73.6% | — | ||
| Q4 25 | 74.6% | — | ||
| Q3 25 | 80.7% | — | ||
| Q2 25 | 69.4% | — | ||
| Q1 25 | 67.6% | — | ||
| Q4 24 | 62.0% | — | ||
| Q3 24 | 64.1% | — | ||
| Q2 24 | 55.3% | — |
营业利润率
ADPT
ASTS
| Q1 26 | -27.1% | -560.4% | ||
| Q4 25 | -17.8% | -175.0% | ||
| Q3 25 | 10.9% | -1109.0% | ||
| Q2 25 | -42.5% | — | ||
| Q1 25 | -56.4% | — | ||
| Q4 24 | -71.3% | — | ||
| Q3 24 | -70.3% | — | ||
| Q2 24 | -109.6% | — |
净利率
ADPT
ASTS
| Q1 26 | 4.7% | — | ||
| Q4 25 | -18.9% | -136.2% | ||
| Q3 25 | 10.2% | -833.7% | ||
| Q2 25 | -43.5% | — | ||
| Q1 25 | -56.9% | — | ||
| Q4 24 | -71.0% | — | ||
| Q3 24 | -69.1% | — | ||
| Q2 24 | -107.0% | — |
每股收益(稀释后)
ADPT
ASTS
| Q1 26 | — | — | ||
| Q4 25 | $-0.08 | — | ||
| Q3 25 | $0.06 | — | ||
| Q2 25 | $-0.17 | — | ||
| Q1 25 | $-0.20 | — | ||
| Q4 24 | $-0.22 | — | ||
| Q3 24 | $-0.22 | — | ||
| Q2 24 | $-0.31 | — |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | ||
|---|---|---|
| 现金及短期投资手头流动性 | $77.6M | $2.3B |
| 总债务越低越好 | — | $12.0M |
| 股东权益账面价值 | — | $2.4B |
| 总资产 | $505.9M | $5.0B |
| 负债/权益比越低杠杆越低 | — | 0.01× |
8季度趋势,按日历期对齐
现金及短期投资
ADPT
ASTS
| Q1 26 | $77.6M | $2.3B | ||
| Q4 25 | $70.5M | $4.3B | ||
| Q3 25 | $55.0M | $2.4B | ||
| Q2 25 | $43.2M | — | ||
| Q1 25 | $50.6M | — | ||
| Q4 24 | $47.9M | — | ||
| Q3 24 | $38.1M | — | ||
| Q2 24 | $59.8M | — |
总债务
ADPT
ASTS
| Q1 26 | — | $12.0M | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
股东权益
ADPT
ASTS
| Q1 26 | — | $2.4B | ||
| Q4 25 | $218.8M | $2.4B | ||
| Q3 25 | $204.4M | $1.6B | ||
| Q2 25 | $179.7M | — | ||
| Q1 25 | $190.4M | — | ||
| Q4 24 | $202.7M | — | ||
| Q3 24 | $223.8M | — | ||
| Q2 24 | $241.6M | — |
总资产
ADPT
ASTS
| Q1 26 | $505.9M | $5.0B | ||
| Q4 25 | $512.7M | $5.0B | ||
| Q3 25 | $490.6M | $2.6B | ||
| Q2 25 | $496.6M | — | ||
| Q1 25 | $510.9M | — | ||
| Q4 24 | $539.4M | — | ||
| Q3 24 | $558.5M | — | ||
| Q2 24 | $584.9M | — |
负债/权益比
ADPT
ASTS
| Q1 26 | — | 0.01× | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图